Financial statements Biomedycyna Polska W Likwidacji
Balance sheet of Biomedycyna Polska W Likwidacji
Company age:
Age:
6 y. 8 m. 25 d.
Share capital:
Share capital:
1 000 000 PLN
Balance sheet data of BIOMEDYCYNA POLSKA W LIKWIDACJI
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 1 354 113,03 | 6 944 582,53 | 6 631 777,92 | 6 513 954,62 | 6 421 205,03 |
| A. Fixed assets | 1 297 417,34 | 6 347 570,98 | 6 556 539,70 | 6 450 063,62 | 6 347 541,27 |
| B. Current assets | 56 695,69 | 597 011,55 | 75 238,22 | 63 891,00 | 73 663,76 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 345 113,03 | 6 944 582,53 | 6 631 777,92 | 6 513 954,62 | 6 421 205,03 |
| A. Equity | 501 458,92 | 6 880 667,50 | 6 627 693,83 | 6 508 395,36 | 6 418 254,77 |
| B. Liabilities and provisions for liabilities | 852 654,11 | 63 915,03 | 4 084,09 | 5 559,26 | 2 950,26 |
| I. Long-term liabilities | - | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | - | 63 915,03 | 4 084,09 | 5 559,26 | 2 950,26 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.
AD
AD